Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cytotoxicity as a form of immunogenic cell death leading to efficient tumor antigen cross‐priming
Authors
Keywords
-
Journal
IMMUNOLOGICAL REVIEWS
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2023-10-12
DOI
10.1111/imr.13281
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Intratumoral BO-112 in combination with radiotherapy synergizes to achieve CD8 T-cell-mediated local tumor control
- (2023) Maria E Rodriguez-Ruiz et al. Journal for ImmunoTherapy of Cancer
- Tumor-derived prostaglandin E2 programs cDC1 dysfunction to impair intratumoral orchestration of anti-cancer T cell responses
- (2023) Felix Bayerl et al. IMMUNITY
- Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
- (2023) Assaf Magen et al. NATURE MEDICINE
- Perforin-2 is a pore-forming effector of endocytic escape in cross-presenting dendritic cells
- (2023) Pablo Rodríguez-Silvestre et al. SCIENCE
- The evolving biology of cross-presentation
- (2023) Ray A. Ohara et al. SEMINARS IN IMMUNOLOGY
- mRNAs encoding IL-12 and a decoy-resistant variant of IL-18 synergize to engineer T cells for efficacious intratumoral adoptive immunotherapy
- (2023) Irene Olivera et al. Cell Reports Medicine
- A distinct stimulatory cDC1 subpopulation amplifies CD8+ T cell responses in tumors for protective anti-cancer immunity
- (2023) Philippa Meiser et al. CANCER CELL
- Dendritic cells can prime anti-tumor CD8+ T cell responses through major histocompatibility complex cross-dressing
- (2022) Brendan W. MacNabb et al. IMMUNITY
- DCs at the center of help: Origins and evolution of the three-cell-type hypothesis
- (2022) Renee Wu et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Depletion of conventional type-1 dendritic cells in established tumors suppresses immunotherapy efficacy
- (2022) Alvaro Teijeira et al. CANCER RESEARCH
- CD8+ T cell activation in cancer comprises an initial activation phase in lymph nodes followed by effector differentiation within the tumor
- (2022) Nataliya Prokhnevska et al. IMMUNITY
- Engineered Lactococcus lactis secreting Flt3L and OX40 ligand for in situ vaccination-based cancer immunotherapy
- (2022) Junmeng Zhu et al. Nature Communications
- Expanding cross-presenting dendritic cells enhances oncolytic virotherapy and is critical for long-term anti-tumor immunity
- (2022) Judit Svensson-Arvelund et al. Nature Communications
- Dendritic Cells Revisited
- (2021) Mar Cabeza-Cabrerizo et al. Annual Review of Immunology
- TIM4 expression by dendritic cells mediates uptake of tumor-associated antigens and anti-tumor responses
- (2021) Nicoletta Caronni et al. Nature Communications
- DNGR-1 limits Flt3L-mediated antitumor immunity by restraining tumor-infiltrating type I conventional dendritic cells
- (2021) Francisco J Cueto et al. Journal for ImmunoTherapy of Cancer
- Secreted gelsolin inhibits DNGR-1-dependent cross-presentation and cancer immunity
- (2021) Evangelos Giampazolias et al. CELL
- Type I interferon activates MHC class I-dressed CD11b+ conventional dendritic cells to promote protective anti-tumor CD8+ T cell immunity
- (2021) Ellen Duong et al. IMMUNITY
- Cellular origins of dsRNA, their recognition and consequences
- (2021) Y. Grace Chen et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Dendritic cell paucity in mismatch repair–proficient colorectal cancer liver metastases limits immune checkpoint blockade efficacy
- (2021) William W. Ho et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Epitope spreading driven by the joint action of CART cells and pharmacological STING stimulation counteracts tumor escape via antigen-loss variants
- (2021) Enrique Conde et al. Journal for ImmunoTherapy of Cancer
- Intratumoral co-injection of the poly I:C-derivative BO-112 and a STING agonist synergize to achieve local and distant anti-tumor efficacy
- (2021) Maite Alvarez et al. Journal for ImmunoTherapy of Cancer
- A conserved dendritic-cell regulatory program limits antitumour immunity
- (2020) Barbara Maier et al. NATURE
- Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity
- (2020) Junyun Lai et al. NATURE IMMUNOLOGY
- Cell death induced by cytotoxic CD8+T cells is immunogenic and primes caspase-3–dependent spread immunity against endogenous tumor antigens
- (2020) Paula Jaime-Sanchez et al. Journal for ImmunoTherapy of Cancer
- Cellular cytotoxicity is a form of immunogenic cell death
- (2020) Luna Minute et al. Journal for ImmunoTherapy of Cancer
- Visualizing Synaptic Transfer of Tumor Antigens among Dendritic Cells
- (2020) Megan K. Ruhland et al. CANCER CELL
- cDC1 prime and are licensed by CD4+ T cells to induce anti-tumour immunity
- (2020) Stephen T. Ferris et al. NATURE
- Systemic clinical tumor regressions and potentiation of PD1 blockade with in situ vaccination
- (2019) Linda Hammerich et al. NATURE MEDICINE
- Cryptic activation of an Irf8 enhancer governs cDC1 fate specification
- (2019) Vivek Durai et al. NATURE IMMUNOLOGY
- Intratumor Adoptive Transfer of IL-12 mRNA Transiently Engineered Antitumor CD8+ T Cells
- (2019) Iñaki Etxeberria et al. CANCER CELL
- Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018
- (2018) Lorenzo Galluzzi et al. CELL DEATH AND DIFFERENTIATION
- Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
- (2018) Paula Michea et al. NATURE IMMUNOLOGY
- A natural killer–dendritic cell axis defines checkpoint therapy–responsive tumor microenvironments
- (2018) Kevin C. Barry et al. NATURE MEDICINE
- Neoadjuvant PD-1 Blockade in Resectable Lung Cancer
- (2018) Patrick M. Forde et al. NEW ENGLAND JOURNAL OF MEDICINE
- Critical role of integrin CD11c in splenic dendritic cell capture of missing-self CD47 cells to induce adaptive immunity
- (2018) Jiaxi Wu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Intratumoral Immunotherapy with XCL1 and sFlt3L Encoded in Recombinant Semliki Forest Virus–Derived Vectors Fosters Dendritic Cell–Mediated T-cell Cross-Priming
- (2018) Alfonso R. Sánchez-Paulete et al. CANCER RESEARCH
- WDFY4 is required for cross-presentation in response to viral and tumor antigens
- (2018) Derek J. Theisen et al. SCIENCE
- Critical role for Sec22b-dependent antigen cross-presentation in antitumor immunity
- (2017) Andrés Alloatti et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Intratumoral STING Activation with T-cell Checkpoint Modulation Generates Systemic Antitumor Immunity
- (2017) Casey R. Ager et al. Cancer Immunology Research
- Transcriptional Control of Dendritic Cell Development
- (2016) Theresa L. Murphy et al. Annual Review of Immunology
- Critical Role for CD103 + /CD141 + Dendritic Cells Bearing CCR7 for Tumor Antigen Trafficking and Priming of T Cell Immunity in Melanoma
- (2016) Edward W. Roberts et al. CANCER CELL
- Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming
- (2016) M. E. Rodriguez-Ruiz et al. CANCER RESEARCH
- Expansion and Activation of CD103 + Dendritic Cell Progenitors at the Tumor Site Enhances Tumor Responses to Therapeutic PD-L1 and BRAF Inhibition
- (2016) Hélène Salmon et al. IMMUNITY
- RAB43 facilitates cross-presentation of cell-associated antigens by CD8α + dendritic cells
- (2016) Nicole M. Kretzer et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Visualization of immediate immune responses to pioneer metastatic cells in the lung
- (2016) Mark B. Headley et al. NATURE
- Density of immunogenic antigens does not explain the presence or absence of the T-cell–inflamed tumor microenvironment in melanoma
- (2016) Stefani Spranger et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chemotherapy-induced antitumor immunity requires formyl peptide receptor 1
- (2015) E. Vacchelli et al. SCIENCE
- Id1 suppresses anti-tumour immune responses and promotes tumour progression by impairing myeloid cell maturation
- (2015) Marianna Papaspyridonos et al. Nature Communications
- Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells
- (2015) A. R. Sanchez-Paulete et al. Cancer Discovery
- Dissecting the Tumor Myeloid Compartment Reveals Rare Activating Antigen-Presenting Cells Critical for T Cell Immunity
- (2014) Miranda L. Broz et al. CANCER CELL
- An AXL/LRP-1/RANBP9 complex mediates DC efferocytosis and antigen cross-presentation in vivo
- (2014) Manikandan Subramanian et al. JOURNAL OF CLINICAL INVESTIGATION
- Cancer cell–autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
- (2014) Antonella Sistigu et al. NATURE MEDICINE
- Oncology Meets Immunology: The Cancer-Immunity Cycle
- (2013) Daniel S. Chen et al. IMMUNITY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- NFIL3/E4BP4 is a key transcription factor for CD8 + dendritic cell development
- (2011) M. Kashiwada et al. BLOOD
- Host type I IFN signals are required for antitumor CD8+T cell responses through CD8α+dendritic cells
- (2011) Mercedes B. Fuertes et al. JOURNAL OF EXPERIMENTAL MEDICINE
- CD91-dependent programming of T-helper cell responses following heat shock protein immunization
- (2011) Sudesh Pawaria et al. Nature Communications
- The purinergic receptor P2Y2 receptor mediates chemotaxis of dendritic cells and eosinophils in allergic lung inflammation
- (2010) T. Müller et al. ALLERGY
- In situ Stimulation of CD40 and Toll-like Receptor 3 Transforms Ovarian Cancer-Infiltrating Dendritic Cells from Immunosuppressive to Immunostimulatory Cells
- (2009) U. K. Scarlett et al. CANCER RESEARCH
- Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
- (2009) Theocharis Panaretakis et al. EMBO JOURNAL
- Identification of a dendritic cell receptor that couples sensing of necrosis to immunity
- (2009) David Sancho et al. NATURE
- Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β–dependent adaptive immunity against tumors
- (2009) François Ghiringhelli et al. NATURE MEDICINE
- Targeting Tumor Antigens to Secreted Membrane Vesicles In vivo Induces Efficient Antitumor Immune Responses
- (2008) I. S. Zeelenberg et al. CANCER RESEARCH
- Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity
- (2008) K. Hildner et al. SCIENCE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now